Market Overview:
The global human rotavirus vaccine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of rotavirus infections, rising demand for pediatric vaccines, and growing investments by key players in this market. The global human rotavirus vaccine market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into Rotarix, RotaTeq, Rotavac, Rotavin-M1 (China), Lanzhou lamb (China), and others. On the basis of application, hospitals & clinics accounted for a major share of the global human rotavirus vaccine market in 2017. This can be attributed to factors such as rising number of hospital admissions owing to severe cases of rotaviral diarrhea and increasing awareness about vaccination among healthcare professionals worldwide. However; academic & research institutions are projected to witness highest growth during the forecast period owing to growing focus on R&D activities for development new vaccines against various strainsRotoviruses .
Product Definition:
Rotavirus vaccine is a vaccine that protects against rotavirus infection. Rotavirus is a virus that can cause severe diarrhea, vomiting, and dehydration in young children. The vaccine is given as a series of three shots, usually starting at 2 months of age.
Rotarix:
Rotarix is a vaccine against rotavirus, the leading cause of diarrhea in children. It is developed by GlaxoSmithKline Biologicals and was approved for use in Europe and Japan in 2005 and 2006 respectively. The vaccine was approved for sale in the U.
RotaTeq:
RotaTeq is a non-commercial vaccine developed by the University of Queensland. It was created as part of the university's research project to develop a human rotavirus vaccine. The project was funded by the Australian government and carried out in collaboration with Sanofi Pasteur, Novartis, and GlaxoSmithKline (GSK). GSK holds a license for RotaTeq under its proprietary brand Sotradecol.
Application Insights:
The hospital and clinic application segment dominated the global market in 2017, accounting for over 70% of the total revenue share. The growth can be attributed to increasing number of immunization clinics at hospitals and clinics across the world. Moreover, introduction of a new rotavirus vaccine by manufacturers such as GSK that is more effective than other vaccines will drive demand in this segment.
The academic and research application segment accounted for a significant revenue share in 2017 due to extensive R&D initiatives undertaken by various institutions to develop improved vaccines against rotavirus gastroenteritis. For instance, research studies conducted by Centers for Disease Control & Prevention (CDC) have established that under-five children who received two doses of Rotarix were less likely to get dehydrated compared with children who received one dose or no dose at all. This information was used by CDC along with manufacturer Pfizer Inc.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of manufacturers and research institutes involved in developing rotavirus vaccines is one of the major factors contributing to its largest share. Furthermore, increasing awareness about immunization programs among parents has also contributed to this region’s large share.
Asia Pacific is expected to be the fastest-growing regional market during the forecast period owing to an increase in government spending on immunization programs coupled with rising demand for improved healthcare services across emerging economies such as China and India. Moreover, these countries have a high incidence rate of rotavirus disease due to lack of proper hygiene and sanitation facilities which results in increased demand for vaccine development initiatives by governments as well as private firms.
Growth Factors:
- Increasing incidence of rotavirus infections in children across the globe
- Growing awareness about the benefits of human rotavirus vaccine among parents and healthcare professionals
- Rising demand for human rotavirus vaccine due to increasing number of outbreaks and epidemics globally
- Technological advancements in the manufacturing of human rotavirus vaccines that improve their efficacy and safety profile
- Availability of government funding for purchase of human rotavirus vaccines by developing countries
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Rotavirus Vaccine Market Research Report
By Type
Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Others
By Application
Hospitals & Clinics, Academic And Research, Others
By Companies
Bharat Biotech, Merck, GlaxoSmithKline
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Human Rotavirus Vaccine Market Report Segments:
The global Human Rotavirus Vaccine market is segmented on the basis of:
Types
Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Clinics, Academic And Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bharat Biotech
- Merck
- GlaxoSmithKline
Highlights of The Human Rotavirus Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rotarix
- RotaTeq
- Rotavac
- Rotavin-M1
- Lanzhou lamb
- Others
- By Application:
- Hospitals & Clinics
- Academic And Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Rotavirus Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human rotavirus vaccine is a vaccine that helps protect against rotavirus, a virus that can cause severe diarrhea in children. Rotavirus is highly contagious and can be spread through contact with respiratory secretions, such as saliva or mucus, from an infected person. Human rotavirus vaccine is available in both pre- and post-marketing formulations. Pre-marketing formulations are not yet licensed for use in the United States but have been shown to be safe and effective when used according to the manufacturer's instructions. Post-marketing formulations are licensed for use in the United States but may not be available everywhere.
Some of the major companies in the human rotavirus vaccine market are Bharat Biotech, Merck, GlaxoSmithKline.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Human Rotavirus Vaccine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Human Rotavirus Vaccine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Human Rotavirus Vaccine Market - Supply Chain
4.5. Global Human Rotavirus Vaccine Market Forecast
4.5.1. Human Rotavirus Vaccine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Human Rotavirus Vaccine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Human Rotavirus Vaccine Market Absolute $ Opportunity
5. Global Human Rotavirus Vaccine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Human Rotavirus Vaccine Market Size and Volume Forecast by Type
5.3.1. Rotarix
5.3.2. RotaTeq
5.3.3. Rotavac
5.3.4. Rotavin-M1
5.3.5. Lanzhou lamb
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Human Rotavirus Vaccine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Human Rotavirus Vaccine Market Size and Volume Forecast by Application
6.3.1. Hospitals & Clinics
6.3.2. Academic And Research
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Human Rotavirus Vaccine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Human Rotavirus Vaccine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Human Rotavirus Vaccine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Human Rotavirus Vaccine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Human Rotavirus Vaccine Demand Share Forecast, 2019-2026
9. North America Human Rotavirus Vaccine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Human Rotavirus Vaccine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Human Rotavirus Vaccine Market Size and Volume Forecast by Application
9.4.1. Hospitals & Clinics
9.4.2. Academic And Research
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Human Rotavirus Vaccine Market Size and Volume Forecast by Type
9.7.1. Rotarix
9.7.2. RotaTeq
9.7.3. Rotavac
9.7.4. Rotavin-M1
9.7.5. Lanzhou lamb
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Human Rotavirus Vaccine Demand Share Forecast, 2019-2026
10. Latin America Human Rotavirus Vaccine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Human Rotavirus Vaccine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Human Rotavirus Vaccine Market Size and Volume Forecast by Application
10.4.1. Hospitals & Clinics
10.4.2. Academic And Research
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Human Rotavirus Vaccine Market Size and Volume Forecast by Type
10.7.1. Rotarix
10.7.2. RotaTeq
10.7.3. Rotavac
10.7.4. Rotavin-M1
10.7.5. Lanzhou lamb
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Human Rotavirus Vaccine Demand Share Forecast, 2019-2026
11. Europe Human Rotavirus Vaccine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Human Rotavirus Vaccine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Human Rotavirus Vaccine Market Size and Volume Forecast by Application
11.4.1. Hospitals & Clinics
11.4.2. Academic And Research
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Human Rotavirus Vaccine Market Size and Volume Forecast by Type
11.7.1. Rotarix
11.7.2. RotaTeq
11.7.3. Rotavac
11.7.4. Rotavin-M1
11.7.5. Lanzhou lamb
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Human Rotavirus Vaccine Demand Share, 2019-2026
12. Asia Pacific Human Rotavirus Vaccine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Human Rotavirus Vaccine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Human Rotavirus Vaccine Market Size and Volume Forecast by Application
12.4.1. Hospitals & Clinics
12.4.2. Academic And Research
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Human Rotavirus Vaccine Market Size and Volume Forecast by Type
12.7.1. Rotarix
12.7.2. RotaTeq
12.7.3. Rotavac
12.7.4. Rotavin-M1
12.7.5. Lanzhou lamb
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Human Rotavirus Vaccine Demand Share, 2019-2026
13. Middle East & Africa Human Rotavirus Vaccine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Human Rotavirus Vaccine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Human Rotavirus Vaccine Market Size and Volume Forecast by Application
13.4.1. Hospitals & Clinics
13.4.2. Academic And Research
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Human Rotavirus Vaccine Market Size and Volume Forecast by Type
13.7.1. Rotarix
13.7.2. RotaTeq
13.7.3. Rotavac
13.7.4. Rotavin-M1
13.7.5. Lanzhou lamb
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Human Rotavirus Vaccine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Human Rotavirus Vaccine Market: Market Share Analysis
14.2. Human Rotavirus Vaccine Distributors and Customers
14.3. Human Rotavirus Vaccine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bharat Biotech
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. GlaxoSmithKline
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook